Syringe Filling Machine Market Size, Share, Trends & Research Report, 2030

Name: Syringe Filling Machine Market Size, Share, Trends & Research Report, 2030
Creator: Mordor Intelligence
License: https://www.mordorintelligence.com/privacy-policy

Syringe Filling Machine Market Size and Share

Market Overview

Study Period	2019 - 2030
Market Size (2025)	USD 1.95 Billion
Market Size (2030)	USD 2.80 Billion
Growth Rate (2025 - 2030)	7.50% CAGR
Fastest Growing Market	Asia Pacific
Largest Market	North America
Market Concentration	Low
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Syringe Filling Machine Market (2025 - 2030) — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Syringe Filling Machine Market Analysis by Mordor Intelligence

The syringe filling machine market size reached USD 1.95 billion in 2025 and is forecast to climb to USD 2.80 billion by 2030, reflecting a 7.5% CAGR during the period. Growth is propelled by the pharmaceutical sector’s rapid embrace of automated aseptic processing in response to stricter global regulations and a swelling biologics pipeline that mandates precise, contamination-free filling. Investments in high-speed commercial systems, adoption of ready-to-use containers, and the expansion of contract manufacturing organizations continue to widen the syringe filling machine market’s addressable base. North American capacity expansions that answer quality concerns tied to imported syringes, Asia-Pacific regulatory harmonization, and hospital pharmacy automation further reinforce demand. At the same time, consolidation among leading vendors underscores the strategic importance of vertical integration, intellectual property, and service portfolios in defending competitive positions.

Key Report Takeaways

By automation type, automated systems led with 64.58% syringe filling machine market share in 2024, while the same segment is advancing at 9.67% CAGR through 2030.
By technology, servo-driven piston systems commanded 44.56% share of the syringe filling machine market size in 2024 and are expanding at 10.17% CAGR to 2030.
By output capacity, high-speed systems (>18,000 SPH) held 28.45% share in 2024; mid-scale lines (6,001-18,000 SPH) are growing fastest at 8.14% CAGR through 2030.
By end-user, pharmaceutical manufacturers accounted for 45.34% of the syringe filling machine market in 2024, whereas hospital and compounding pharmacies exhibit the highest growth at 10.57% CAGR to 2030.
By region, North America dominated with 42.89% share in 2024, while Asia-Pacific posts the strongest regional CAGR at 11.15% through 2030.

Global Syringe Filling Machine Market Trends and Insights

Drivers Impact Analysis

Driver	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
Rising demand for pre-filled syringes	+1.8%	Global, with concentration in North America and Europe	Medium term (2-4 years)
Shift toward high-speed automated fill-finish lines for biologics	+1.5%	Global, Asia-Pacific core with spill-over to North America	Long term (≥ 4 years)
Adoption of ready-to-use (RTU) nested syringe formats	+1.2%	Europe and North America, expanding to Asia-Pacific	Medium term (2-4 years)
Stringent regulatory focus on aseptic accuracy	+1.0%	Global, with early implementation in EU and US	Short term (≤ 2 years)
Growing CMO outsourcing among small biotech firms	+0.8%	Global, with concentration in Asia-Pacific	Long term (≥ 4 years)
AI-driven predictive maintenance to cut downtime	+0.7%	North America and Europe, expanding globally	Medium term (2-4 years)
Source: Mordor Intelligence

Rising Demand for Pre-filled Syringes

Elevated patient convenience, reduced contamination risk, and regulatory encouragement continue to shift injectable drug delivery toward pre-filled syringes. BD expanded Neopak XtraFlow glass syringe capacity sevenfold at Le Pont-de-Claix to support high-viscosity biologics, confirming soaring industrial uptake.^{[1]BD, “BD and Ypsomed Collaborate to Advance Self-Injection Systems for High-Viscosity Biologics,” news.bd.com} Collaboration between BD and Ypsomed that marries XtraFlow syringes with autoinjectors underscores device-platform co-development. Equipment makers supplying servo-driven piston systems optimized for nested, pre-sterilized formats secure a meaningful advantage as manufacturers demand sterility assurance levels beyond traditional vial lines. The preference of hospital pharmacies for pre-filled units that simplify bedside administration further fuels the syringe filling machine market.

Shift Toward High-Speed Automated Fill-Finish Lines for Biologics

Biologics now represent one-fifth of pharmaceutical sales and require gentle, contamination-free handling. WuXi Biologics achieved 99.5% quality acceptance on Cytiva’s SA25 robotic workcell that fills vials, syringes, and cartridges in closed conditions. The emergence of large-volume subcutaneous injections up to 20 mL places a premium on volumetric accuracy over prolonged cycles. With contract manufacturers projected to hold 54% of global biologics capacity by 2028, versatile high-throughput systems that traverse multiple jurisdictions gain traction.

Adoption of Ready-to-Use (RTU) Nested Syringe Formats

EU GMP Annex 1 revisions highlight RTU containers as an effective contamination-control tool, prompting redesigns of fill-finish suites around pre-sterilized nest.^{[2]PDA, “GMP Annex 1 Implementation,” pda.org} Syntegon’s MLD Advanced line handles RTU nests at 400 syringes per minute with no-touch transfer and integrated weighing for documentation. Groninger case studies show three-fold capacity gains for Merz Pharma after switching to flexfill RTU solutions. Reduced facility footprints and simplified validation make RTU technology attractive for smaller biotech firms with limited cleanroom real estate.

Stringent Regulatory Focus on Aseptic Accuracy

The EMA clarified maximum bioburden levels of 10 CFU/100 mL and endorsed rapid microbial methods, raising quantitative performance bars for filling lines. Real-time 5 μm particle monitoring in Grade A/B zones and FDA airflow velocity guidance compel equipment makers to boost environmental controls and data logging. Platforms embedding quality-risk-management modules and trend analytics satisfy the expanding documentation burden and secure faster approvals.

Restraints Impact Analysis

Restraint	(~) % Impact on CAGR Forecast	Geographic Relevance	Impact Timeline
High capital expenditure and validation costs	-1.2%	Global, particularly impacting emerging markets	Short term (≤ 2 years)
Limited flexibility of legacy equipment	-0.8%	North America and Europe with aging infrastructure	Medium term (2-4 years)
Skilled-operator shortages in emerging markets	-0.6%	APAC core, spill-over to MEA and South America	Long term (≥ 4 years)
Sustainability pressure on single-use fluid paths	-0.4%	Europe and North America, expanding globally	Medium term (2-4 years)
Source: Mordor Intelligence

High Capital Expenditure and Validation Costs

Modern syringe filling systems often exceed USD 2 million, and full validation can stretch 18 months, discouraging smaller firms. Argonaut Manufacturing Services allocated USD 45 million for a new Carlsbad aseptic facility,^{[3]Business Wire, “Argonaut Manufacturing Services Expands Aseptic Pharmaceutical Fill-Finish Capabilities,” via.ritzau.dk} illustrating the financial weight of competitive entry. Rising raw-material prices—steel surpassing USD 800 per ton—and tariff impacts reported by West Pharmaceutical inflate project budgets. Cleanroom build-outs, personnel training, and digital documentation platforms further raise total cost of ownership.

Limited Flexibility of Legacy Equipment

Older vial-centric systems cannot accommodate RTU nests or high-viscosity biologics, forcing replacement or extensive retrofits. Hospital pharmacies that kept 14-year-old dispensing robots experienced escalating failures, prompting complete upgrades. Integration gaps between legacy hardware and modern quality-management software add compliance risk. Nordson’s portfolio reshuffle, including divestitures, highlights vendors’ need to focus on adaptable technologies.

Segment Analysis

By Type: Automation Drives Market Transformation

Automated platforms accounted for 64.58% of the syringe filling machine market in 2024, and the segment is rising at 9.67% CAGR toward 2030 as regulators promote contamination-free processes. The convergence of high market share and high growth positions automation as the dominant paradigm. Manual and semi-automated setups persist where batch flexibility trumps throughput, yet their relevance diminishes in cGMP environments that increasingly favor enclosed, robotic modules.

Automation’s ascent is fueled by Annex 1 updates encouraging closed systems that curb human contact. Installations such as Cytiva’s SA25 workcells at WuXi Biologics achieve 99.5% acceptance, validating productivity and compliance benefits. Hospital pharmacies extend the same logic, adopting IntelliFill IV robots that slash medication-prep errors. As these gains become industry expectations, automated units cement their role in the syringe filling machine market.

Syringe Filling Machine Market: Market Share by Type — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By Technology: Servo-Driven Systems Lead Innovation

Servo-driven piston technology controlled 44.56% of the syringe filling machine market size in 2024 and is advancing at 10.17% CAGR. Superior volumetric control across viscosities, especially for protein-rich biologics, drives adoption. Peristaltic pumps still serve shear-sensitive formulations, while time-pressure and gravity systems remain in legacy niches.

Syntegon’s MLD Advanced leverages servo precision to reach 400 syringes per minute and document every dispense for regulators. Nordson’s PICO Nexμs couples servo jets with predictive analytics, exemplifying convergence of mechanical accuracy and digital oversight. Patent filings describing dual-stage force profiles attest to continuous gains in servo actuation finesse.

By Output Capacity: Mid-Scale Systems Gain Momentum

High-speed lines exceeding 18,000 SPH held 28.45% market share in 2024. Yet mid-scale units (6,001-18,000 SPH) exhibit the fastest 8.14% CAGR as producers juggle commercial runs with smaller biologics batches. Lab-scale systems address early-stage research where volume requirements stay modest.

Vetter’s commercial line that fills 800 RTU syringes per minute under RABS demonstrates elevated output within a mid-scale footprint. Flexible design supports frequent format changes without prolonged downtime, matching evolving product portfolios. Hospitals deploy similar capacity in automated dispensing centers that handle thousands of doses daily, underscoring breadth of mid-scale demand.

Syringe Filling Machine Market: Market Share by Output Capacity — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By End-User: Hospital Pharmacies Drive Growth

Pharmaceutical manufacturers commanded 45.34% of the syringe filling machine market share in 2024, fortified by entrenched infrastructure and blockbuster pipelines. Nevertheless, hospital and compounding pharmacies grow quickest at 10.57% CAGR. Automation cuts labor costs, mitigates error, and complies with traceability mandates for compounded sterile preparations.

North Luxembourg hospital center captured EUR 4 million efficiency gains after adopting automated dispensing, demonstrating financial incentives. Helsinki University Hospital manages 80,000 SKUs using NewIcon Mega-Fixu, pairing real-time stock monitoring with GMP compliance. Vendors fine-tune interfaces and lot-tracking to hospital workflows, broadening penetration.

Geography Analysis

North America retained 42.89% syringe filling machine market share in 2024 on the back of domestic capacity expansions and regulatory vigilance that favors local sourcing. BD’s boost to US syringe output responded directly to FDA warnings on imported devices, exemplifying policy-driven reshoring. Regional manufacturers such as Nordson pioneer predictive maintenance and Industry 4.0 features, embedding competitive technology advantages. Consolidation deals—Nordson’s USD 800 million Atrion purchase—indicate available capital and strategic drive for portfolio depth.

Europe maintains significant presence through regulatory leadership. Annex 1 revisions guide global aseptic norms, and equipment makers like Syntegon tailor offerings to ready-to-use requirements, achieving 400-unit-per-minute outputs while satisfying no-touch imperatives. Nipro’s investment in its Münnerstadt plant widens European PFS supply and emphasizes sustainable practices such as energy-efficient washing lines. Digital twin projects backed by ISPE and EU research grants illustrate the region’s innovation ecosystem.

Asia-Pacific is the fastest-growing territory at 11.15% CAGR to 2030. China’s NMPA standards YY 1001-2024 frame stringent syringe quality metrics, fostering domestic demand for compliant. WuXi Biologics achieved GMP release just 15 months after purchasing the SA25 workcell, underscoring regional execution speed. Samsung Biologics and Daiichi Sankyo headline multibillion-dollar expansions that will anchor 45% of global biologics capacity in Asia by 2028. Coupled with government incentives, these investments cement Asia-Pacific as a pivotal hub for the syringe filling machine market.

Syringe Filling Machine Market CAGR (%), Growth Rate by Region — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

Market fragmentation coexists with mounting consolidation. Technology differentiation, regulatory proficiency, and service breadth outweigh pure manufacturing scale. BD’s USD 4.2 billion acquisition of Edwards Lifesciences’ Critical Care division reinforces vertical integration aimed at supplying devices, disposables, and filling solutions under one roof. Syntegon focuses on RTU equipment while Cytiva advances robotic workcells that deliver near-perfect acceptance rates, highlighting specialization paths.

Patent activity clusters around servo actuation and single-use module design, illustrating a pipeline of incremental but commercially relevant innovations. Mid-market players leverage niche expertise—for example, Groninger’s flexfill systems—to capture biotech and hospital contracts where agility trumps volume. Meanwhile, automation suppliers like ARxIUM and NewIcon address downstream hospital needs, expanding the competitive arena beyond traditional pharmaceutical equipment vendors.

Strategic partnerships proliferate as firms seek complete solutions. BD collaborates with Ypsomed on high-viscosity autoinjectors, merging container science with delivery technology. IMA Group’s Sarong acquisition augments thermoforming and suppository capabilities that complement fill-finish lines. The fluid competitive landscape rewards companies that integrate digital analytics, RTU compatibility, and service contracts to deepen customer lock-in.

Syringe Filling Machine Industry Leaders

Nordson Corporation
Romaco Group
Added Pharma B.V.
OPTIMA packaging group GmbH
Automated Systems of Tacoma (AST)
*Disclaimer: Major Players sorted in no particular order

Maquinaria Industrial Dara, Sl, Vanrx Pharmasystems Inc., Nordson Corporation, Musashi Engineering, Inc. I.M.A. Industria Macchine Automatiche S.P.A. — Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Need More Details on Market Players and Competitors?

Download PDF

Recent Industry Developments

May 2025: Syntegon launched the MLD Advanced filling machine tailored for RTU nested syringes, reaching 400 syringes/min with integrated weighing.
May 2025: Nipro expanded syringe output at Münnerstadt, adding lines and hiring 100 staff.
April 2025: West Pharmaceutical Services raised guidance despite USD 10 million tariff drag.
February 2025: Argonaut Manufacturing Services secured USD 45 million to enlarge aseptic fill-finish capacity.

Table of Contents for Syringe Filling Machine Industry Report

1. INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Rising demand for pre-filled syringes
- 4.2.2 Shift toward high-speed automated fill-finish lines for biologics
- 4.2.3 Adoption of ready-to-use (RTU) nested syringe formats
- 4.2.4 Stringent regulatory focus on aseptic accuracy
- 4.2.5 Growing CMO outsourcing among small biotech firms
- 4.2.6 AI-driven predictive maintenance to cut downtime
4.3 Market Restraints
- 4.3.1 High capital expenditure and validation costs
- 4.3.2 Limited flexibility of legacy equipment
- 4.3.3 Skilled-operator shortages in emerging markets
- 4.3.4 Sustainability pressure on single-use fluid paths
4.4 Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
- 4.7.1 Threat of New Entrants
- 4.7.2 Bargaining Power of Buyers/Consumers
- 4.7.3 Bargaining Power of Suppliers
- 4.7.4 Threat of Substitute Products
- 4.7.5 Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

5.1 By Type
- 5.1.1 Automated
- 5.1.2 Semi-Automated
- 5.1.3 Manual / Benchtop
5.2 By Technology
- 5.2.1 Servo-driven Piston
- 5.2.2 Peristaltic Pump
- 5.2.3 Time-Pressure / Volumetric
- 5.2.4 Vacuum / Gravity
5.3 By Output Capacity (Syringes per hour)
- 5.3.1 Up to 6,000 (Lab / Clinical)
- 5.3.2 6,001 - 18,000 (Mid-scale)
- 5.3.3 Above 18,000 (Commercial High-speed)
5.4 By End-user
- 5.4.1 Pharmaceutical Manufacturing Companies
- 5.4.2 Biotechnology Companies
- 5.4.3 Contract Development and Manufacturing Organizations (CDMOs)
- 5.4.4 Hospital and Compounding Pharmacies
5.5 By Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 France
- 5.5.2.3 United Kingdom
- 5.5.2.4 Italy
- 5.5.2.5 Spain
- 5.5.2.6 Russia
- 5.5.2.7 Netherlands
- 5.5.2.8 Switzerland
- 5.5.2.9 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 Japan
- 5.5.3.3 India
- 5.5.3.4 South Korea
- 5.5.3.5 Australia
- 5.5.3.6 Indonesia
- 5.5.3.7 Thailand
- 5.5.3.8 Malaysia
- 5.5.3.9 Rest of Asia-Pacific
- 5.5.4 Middle East and Africa
- 5.5.4.1 Middle East
- 5.5.4.1.1 Saudi Arabia
- 5.5.4.1.2 United Arab Emirates
- 5.5.4.1.3 Turkey
- 5.5.4.1.4 Rest of Middle East
- 5.5.4.2 Africa
- 5.5.4.2.1 South Africa
- 5.5.4.2.2 Egypt
- 5.5.4.2.3 Nigeria
- 5.5.4.2.4 Kenya
- 5.5.4.2.5 Rest of Africa
- 5.5.5 South America
- 5.5.5.1 Brazil
- 5.5.5.2 Argentina
- 5.5.5.3 Colombia
- 5.5.5.4 Rest of South America

6. COMPETITIVE LANDSCAPE

6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
- 6.4.1 Maquinaria Industrial Dara, S.L.
- 6.4.2 Vanrx Pharmasystems (Cytiva)
- 6.4.3 Nordson Corporation
- 6.4.4 Musashi Engineering, Inc.
- 6.4.5 I.M.A. Industria Macchine Automatiche S.p.A.
- 6.4.6 Romaco Group
- 6.4.7 Added Pharma B.V.
- 6.4.8 Automated Systems of Tacoma (AST)
- 6.4.9 Shenzhen Penglai Industrial Corp. Ltd.
- 6.4.10 OPTIMA Packaging Group GmbH
- 6.4.11 Prosys Innovative Packaging Equipment
- 6.4.12 Syntegon Technology GmbH
- 6.4.13 Becton, Dickinson & Company (BD)
- 6.4.14 Groninger & Co. GmbH
- 6.4.15 Marchesini Group S.p.A.
- 6.4.16 Robert Bosch Manufacturing Solutions GmbH
- 6.4.17 Steriline S.r.l.
- 6.4.18 Coesia S.p.A.
- 6.4.19 Stäubli International AG
- 6.4.20 Shenghi Machinery Co., Ltd.
- 6.4.21 Datwyler Holding Inc.
- 6.4.22 Accutek Packaging Equipment
- 6.4.23 TurboFil Packaging Machines
- 6.4.24 Vetter Pharma-Fertigung GmbH & Co. KG

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

7.1 White-space and Unmet-Need Assessment

You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections

Get Price Break-up Now

Global Syringe Filling Machine Market Report Scope

A syringe filling machine fills the pre-sterile syringes with the desired drug. It also enables the user for batch filling of syringes for industries such as pharmaceutical and hospital pharmacy. This report segments the market by Type (Automated, Semiautomated, Manual), End-user Industry(Pharmaceutical, CDMO, and Other End-user Industries) and Geography.

By Type	Automated
	Semi-Automated
	Manual / Benchtop
By Technology	Servo-driven Piston
	Peristaltic Pump
	Time-Pressure / Volumetric
	Vacuum / Gravity
By Output Capacity (Syringes per hour)	Up to 6,000 (Lab / Clinical)
	6,001 - 18,000 (Mid-scale)
	Above 18,000 (Commercial High-speed)
By End-user	Pharmaceutical Manufacturing Companies
	Biotechnology Companies
	Contract Development and Manufacturing Organizations (CDMOs)
	Hospital and Compounding Pharmacies

By Geography	North America	United States
		Canada
		Mexico

	Europe	Germany
		France
		United Kingdom
		Italy
		Spain
		Russia
		Netherlands
		Switzerland
		Rest of Europe

	Asia-Pacific	China
		Japan
		India
		South Korea
		Australia
		Indonesia
		Thailand
		Malaysia
		Rest of Asia-Pacific

	Middle East and Africa	Middle East	Saudi Arabia
			United Arab Emirates
			Turkey
			Rest of Middle East

		Africa	South Africa
			Egypt
			Nigeria
			Kenya
			Rest of Africa

	South America	Brazil
		Argentina
		Colombia
		Rest of South America

By Type

Automated

Semi-Automated

Manual / Benchtop

By Technology

Servo-driven Piston

Peristaltic Pump

Time-Pressure / Volumetric

Vacuum / Gravity

By Output Capacity (Syringes per hour)

Up to 6,000 (Lab / Clinical)

6,001 - 18,000 (Mid-scale)

Above 18,000 (Commercial High-speed)

By End-user

Pharmaceutical Manufacturing Companies

Biotechnology Companies

Contract Development and Manufacturing Organizations (CDMOs)

Hospital and Compounding Pharmacies

By Geography

North America	United States
	Canada
	Mexico
Europe	Germany
	France
	United Kingdom
	Italy
	Spain
	Russia
	Netherlands
	Switzerland
	Rest of Europe
Asia-Pacific	China
	Japan
	India
	South Korea
	Australia
	Indonesia
	Thailand
	Malaysia
	Rest of Asia-Pacific

Middle East and Africa	Middle East	Saudi Arabia
		United Arab Emirates
		Turkey
		Rest of Middle East

	Africa	South Africa
		Egypt
		Nigeria
		Kenya
		Rest of Africa
South America	Brazil
	Argentina
	Colombia
	Rest of South America